Anæstesi ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 12.2% 5.8% 3.5%  
Credit score (0-100)  0 0 18 39 52  
Credit rating  N/A N/A BB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 2,264 4,951 4,493  
EBITDA  0.0 0.0 44.0 798 629  
EBIT  0.0 0.0 44.0 794 628  
Pre-tax profit (PTP)  0.0 0.0 43.2 791.9 669.1  
Net earnings  0.0 0.0 31.1 607.3 497.3  
Pre-tax profit without non-rec. items  0.0 0.0 43.2 792 669  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 44.6  
Shareholders equity total  0.0 0.0 71.1 678 576  
Interest-bearing liabilities  0.0 0.0 1.1 0.7 5.1  
Balance sheet total (assets)  0.0 0.0 531 1,219 1,341  

Net Debt  0.0 0.0 -224 -191 -372  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 2,264 4,951 4,493  
Gross profit growth  0.0% 0.0% 0.0% 118.7% -9.3%  
Employees  0 0 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 531 1,219 1,341  
Balance sheet change%  0.0% 0.0% 0.0% 129.7% 10.0%  
Added value  0.0 0.0 44.0 793.8 629.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 -1 43  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 1.9% 16.0% 14.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 8.3% 90.8% 52.5%  
ROI %  0.0% 0.0% 60.9% 211.3% 106.4%  
ROE %  0.0% 0.0% 43.7% 162.1% 79.3%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 13.4% 55.7% 44.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -508.9% -24.0% -59.1%  
Gearing %  0.0% 0.0% 1.6% 0.1% 0.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 139.5% 214.9% 80.1%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 1.2 2.2 1.8  
Current Ratio  0.0 0.0 1.2 2.2 1.7  
Cash and cash equivalent  0.0 0.0 225.0 192.1 376.7  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 71.1 674.9 529.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 44 794 629  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 44 798 629  
EBIT / employee  0 0 44 794 628  
Net earnings / employee  0 0 31 607 497